Comparative Effectiveness of Tocilizumab as Monotherapy Versus TNF inhibitors in Combination with Conventional Synthetic Disease Modifying Antirheu-matic Drugs in Bio-naive Patients with Rheumatoid Arthritis

被引：0

作者：

Lauper, K. ^{[1
,2
]}

Kvien, T. K. ^{[3
]}

Codreanu, C. ^{[4
]}

Hernandez, M., V ^{[5
]}

Iannone, I. ^{[6
]}

Kristianslund, E. K. ^{[3
]}

Lukina, G. ^{[7
]}

Nordstrom, D. C. ^{[8
,9
]}

Pavelka, K. ^{[10
]}

Rotar, Z. ^{[11
]}

Santos, M. J. ^{[12
,13
]}

Gale, S. L. ^{[14
]}

John, M. ^{[15
]}

Luder, Y. ^{[15
]}

Courvoisier, D. S. ^{[1
]}

Gabay, C. ^{[1
,2
]}

机构：

[1] Geneva Univ Hosp, Geneva, Switzerland

[2] SCQM Registry, Zurich, Switzerland

[3] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway

[4] Univ Med & Pharm, Ctr Rheumat Dis, Bucharest, Romania

[5] Hosp Clin Barcelona, Rheumatol Dept, Barcelona, Spain

[6] Univ Hosp Bari, GISEA, Bari, Italy

[7] Inst Rheumatol, ARBITER, Moscow, Russia

[8] ROB FIN Helsinki Univ Hosp, Helsinki, Finland

[9] Univ Helsinki, Helsinki, Finland

[10] Charles Univ Prague, Prague, Czech Republic

[11] Univ Med Ctr Ljubljana, BioRx Si, Ljubljana, Slovenia

[12] Hosp Garcia de Orta, Rheumatol Dept, Almada, Portugal

[13] Reuma Pt, Lisbon, Portugal

[14] Genentech Inc, San Francisco, CA USA

[15] F Hoffmann La Roche, Basel, Switzerland

来源：

SWISS MEDICAL WEEKLY | 2018年 / 148卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SSRP 35

引用

页码：20S / 20S

页数：1

共 50 条

[31] Persistence with Biologic Monotherapy in Comparison with Combination Therapy with Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis; Results from a Rheumatoid Arthritis Cohort
Lau, Arthur
Movahedi, Mohammad
Tatangelo, Mark
Bombardier, Claire
JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1245 - 1246
[32] Persistence with Biologic Monotherapy in Comparison with Combination Therapy with Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis; Results from a Rheumatoid Arthritis Cohort
Lau, Arthur
Movahedi, Mohammad
Tatangelo, Mark
Bombardier, Claire
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[33] Safety and Effectiveness of 6 Months' Etanercept Monotherapy and Combination Therapy in Japanese Patients with Rheumatoid Arthritis: Effect of Concomitant Disease-modifying Antirheumatic Drugs
Koike, Takao
Harigai, Masayoshi
Inokuma, Shigeko
Ishiguro, Naoki
Ryu, Junnosuke
Takeuchi, Tsutomu
Tanaka, Yoshiya
Yamanaka, Hisashi
Hirose, Tomohiro
Yoshinaga, Takunari
Suzukawa, Michio
JOURNAL OF RHEUMATOLOGY, 2013, 40 (10) : 1658 - 1668
[34] An open-label extension study of tocilizumab, in combination with disease modifying anti-rheumatic drugs, in patients with Rheumatoid Arthritis
Hansrajh, V
Rudolph, R.
Tikly, M.
Musenge, E.
CLINICAL RHEUMATOLOGY, 2013, 32 : S146 - S146
[35] Long term effectiveness of RA-1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis
Chopra, Arvind
Saluja, Manjit
Kianifard, Toktam
Chitre, Deepa
Venugopalan, Anuradha
JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2018, 9 (03) : 201 - 208
[36] Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
Leslie R. Harrold
George W. Reed
Jennie Best
Steve Zlotnick
Joel M. Kremer
Rheumatology and Therapy, 2018, 5 : 507 - 523
[37] Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
Harrold, Leslie R.
Reed, George W.
Best, Jennie
Zlotnick, Steve
Kremer, Joel M.
RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 507 - 523
[38] Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
Costello, Ruth E.
Humphreys, Jenny H.
Winthrop, Kevin L.
Dixon, William G.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (12) : 1665 - 1666
[39] Comparison of Tocilizumab As Monotherapy or with Add-on Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis and An Inadequate Response to Previous Treatments.
Bykerk, Vivian
Oestoer, Andrew
Roman Ivorra, Jose Andres
Wollenhaupt, Juergen
Stancati, Andrea
Bernasconi, Corrado
Sibilia, Jean
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S866 - S867
[40] PERSISTENCE WITH BIOLOGIC MONOTHERAPY IN COMPARISON WITH COMBINATION THERAPY WITH DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS; RESULTS FROM AN ONTARIO RHEUMATOID ARTHRITIS COHORT
Lau, A. N.
Movahedi, M.
Tatengelo, M.
Bombardier, C.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 486 - 487

← 1 2 3 4 5 →